Search - tctmd.com

Displaying 221 - 240 of 253

Sort: Relevancy | Date

News Daily News

Registro Danés: El Dabigatran es Seguro y Eficaz en el Mundo Real

Caitlin E. Cox

April 05, 2013

News Daily News

Post-acondicionamiento remoto reduce LRA en pacientes con NSTEMI

March 15, 2013

News Daily News

Una Dosis Baja de Rivaroxaban Reduce los Episodios Trombóticos y Aumenta las Hemorragias tras un STEMI

Yael L. Maxwell

March 09, 2013

News Daily News

Low-Dose Rivaroxaban Reduces Thrombotic Events, Increases Bleeding After STEMI

Yael L. Maxwell

March 09, 2013

News Daily News

US Registry Data Support Wider Adoption of Transradial PCI in STEMI Patients

Caitlin E. Cox

December 19, 2012

News Daily News

Los Datos de un Registro Norteamericano Avalan Someter a los Pacientes STEMI a PCI Transradiales

Caitlin E. Cox

December 19, 2012

News Conference News AHA 2012

Evidence Continues to Support Dabigatran Treatment in A-fib

November 06, 2012

$Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!$

Presentation TCT 2012

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Presenter: Gilles Montalescot

October 25, 2012

Presentation TCT 2012

Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI!

Presenter: Roxana Mehran

October 25, 2012

Presentation TCT 2012

Part 1: Oral Anticoagulants

Presenter: Christopher Granger

October 25, 2012

Presentation TCT 2012

Novel Anticoagulants in Patients with Acute Coronary Syndromes

Presenter: C. Michael Gibson

October 25, 2012

Presentation TCT 2012

The Potential of Otamixaban as a Procedural Anticoagulant

Presenter: Philippe Steg

October 24, 2012

News Daily News

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

October 12, 2012

News Daily News

En la PCI Transradial, comparada con la Heparina, la Bivalirudina No Altera los Índices de Episodios

October 12, 2012

Presentation

Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an ACS

Presenter: Andr?s Kom?csi

October 01, 2012

News Conference News ESC 2012

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Caitlin E. Cox

September 04, 2012

News Conference News ESC 2012

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

Caitlin E. Cox

August 27, 2012

News Conference News ESC 2012

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Caitlin E. Cox

August 26, 2012

News Daily News

Registry Finds Overall Decrease in Post-PCI Bleeding but Not in STEMI

Caitlin E. Cox

June 01, 2012

News Daily News

Un Registro Confirma un Descenso Generalizado de las Hemorragias Post-PCI pero no en los casos de STEMI

Caitlin E. Cox

June 01, 2012

Advertisement

Registro Danés: El Dabigatran es Seguro y Eficaz en el Mundo Real

Post-acondicionamiento remoto reduce LRA en pacientes con NSTEMI

Una Dosis Baja de Rivaroxaban Reduce los Episodios Trombóticos y Aumenta las Hemorragias tras un STEMI

Low-Dose Rivaroxaban Reduces Thrombotic Events, Increases Bleeding After STEMI

US Registry Data Support Wider Adoption of Transradial PCI in STEMI Patients

Los Datos de un Registro Norteamericano Avalan Someter a los Pacientes STEMI a PCI Transradiales

Evidence Continues to Support Dabigatran Treatment in A-fib

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Debate: Bivalirudin Is the Preferred Anticoagulant Strategy During STEMI!

Part 1: Oral Anticoagulants

Novel Anticoagulants in Patients with Acute Coronary Syndromes

The Potential of Otamixaban as a Procedural Anticoagulant

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

En la PCI Transradial, comparada con la Heparina, la Bivalirudina No Altera los Índices de Episodios

Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an ACS

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

ESC Congress 2012 Offers Slate of Guidelines, New MI Definition

Registry Finds Overall Decrease in Post-PCI Bleeding but Not in STEMI

Un Registro Confirma un Descenso Generalizado de las Hemorragias Post-PCI pero no en los casos de STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content